Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.
See solutionsWHAT WE DO
HOW WE DO IT
Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.
See expertiseTherapeutic Expertise
Cross-Therapeutic Expertise
Our experts help you stay at the forefront of the industry - and ahead of change.
See insightsThinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.
Learn moreINTERESTED IN PARTICIPATING?
HEAR FROM REAL PATIENTS
TRIAL SITES
Want to collaborate with us to offer clinical trials at your site? We would welcome the opportunity to discuss.
Learn moreWe are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.
About ParexelWhat can we help you find today?
NEW MEDICINES, NOVEL INSIGHTS
Developing effective, patient-focused therapies that deliver meaningful benefits begins early in development and includes patient insights at every step. Parexel experts offer solutions that keep a sharp and sustained focus on patients.
IN THIS REPORT
SECTION 1
Four solutions to include the patient perspective in early decision-making.
Go to section
SECTION 2
What does it take to generate regulatory-grade patient-reported data?
Go to section
SECTION 3
Inclusive strategies for underrepresented patient groups.
Go to section
Contributing Experts
Jep Poirrier, Ph.D.
Executive Director, Health Economics and Outcomes Research
Ned Wydysh
Vice President, Oncology and Cell and Gene Therapy Practices, Health Advances
Rachel Smith
Therapeutic Area Lead, Rare Diseases
Sangeeta Budhia
Senior Vice President, Pricing & Market Access
Stacy Hurt, M.H.A., M.B.A.
Chief Patient Officer
Vera Zheng
Senior Vice President, Asia/Pacific Strategy and Head of Greater China, Parexel International
Xoli Belgrave
Executive Director, Drug Development Services
Contributing Experts
Jep Poirrier, Ph.D.
Executive Director, Health Economics and Outcomes Research
Ned Wydysh
Vice President, Oncology and Cell and Gene Therapy Practices, Health Advances
Rachel Smith
Therapeutic Area Lead, Rare Diseases
Sangeeta Budhia
Senior Vice President, Pricing & Market Access
Stacy Hurt, M.H.A., M.B.A.
Chief Patient Officer
Vera Zheng
Senior Vice President, Asia/Pacific Strategy and Head of Greater China, Parexel International
Stay current with novel thinking and actionable insights from our experts.
Patient-guided drug development requires more than a 30-minute meeting with patient advocates or aspirational text on a website. It is a systematic approach that begins at the earliest stages of development and informs nearly every decision afterward. Our Office of the Patient helps sponsors make use of patient insights to navigate an increasingly complex reimbursement landscape, mitigate risks, and develop commercially viable products that deliver relevant patient benefits.
